Marisa Wexler is a senior science writer for Myeloma Research News with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of myeloma topics.| Rare Cancer News
Based on a clinical trial, the CAR T-cell therapy was approved for relapsed or refractory precursor B-cell acute lymphoblastic leukemia.| Rare Cancer News